SCHEMBL1698267

SCHEMBL1698267

CC(N)OS(=O)(=O)OC(C)N

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 2/20 0.43
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27747463 0.85
SCHEMBL6014636 0.79 CA1 (0.44) CA1CA2CA9
SCHEMBL10611305 0.78
SCHEMBL22041477 0.75
SCHEMBL222523 0.75
SCHEMBL9161788 0.73
SCHEMBL2526566 0.73
Bromide SCHEMBL10546295 0.73
SCHEMBL10783944 0.73
SCHEMBL560454 0.72 ALDH1A1 (0.59) CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12285508-B2 Hair treatment formulations and uses thereof Chembeau LLC (US) 2025-04-29 US claimed
US-12214065-B2 Diester cosmetic formulations and uses thereof Chembeau LLC (US) 2025-02-04 US claimed
CN-114746511-B Thermosensitive hydrogel composition with reversible sol-gel transition property changed and use thereof 耐思格生物技术株式会社 2024-08-23 CN claimed
US-11801211-B2 Hair treatment formulations and uses thereof Chembeau LLC (US) 2023-10-31 US claimed
US-20230140697-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF Chembeau LLC 2023-05-04 US claimed
US-20230099154-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF Chembeau LLC 2023-03-30 US claimed
US-11491092-B2 Hair treatment formulations and uses thereof Chembeau LLC (US) 2022-11-08 US claimed
CN-109503406-A A method of preparing benzanilide 绍兴文理学院 2019-03-22 CN claimed
CN-109153948-A By using acid clean, disinfection and the bactericidal composition of the reduction atomization of high molecular weight water-in-oil emulsion polymer 埃科莱布美国股份有限公司 2019-01-04 CN claimed
CN-107431014-A Cleaning liquid and cleaning method for material containing silicon oxide containing carbon for regenerating wafer 三菱瓦斯化学株式会社 2017-12-01 CN claimed
CN-102953146-B Method for manufacturing a polyamide nanofibre product by electrospinning 曼·胡默尔有限公司 2017-04-12 CN claimed
CN-103693679-B Ito powder and method of producing same, dispersion liquid and method of ito film 三菱综合材料株式会社 2017-04-12 CN claimed
CN-103693678-B Ito powder and the manufacture method of manufacture method and dispersion liquid and ito film thereof 三菱综合材料株式会社 2016-10-05 CN claimed
US-7943370-B2 Structure, target substance detection element and target substance detection kit CANON KABUSHIKI KAISHA (JP) 2011-05-17 US claimed
US-20090061533-A1 STRUCTURE, TARGET SUBSTANCE DETECTION ELEMENT AND TARGET SUBSTANCE DETECTION KIT CANON KABUSHIKI KAISHA (JP) 2009-03-05 US claimed
CN-1117655-C Mold material made with additives JOHNSON & FOHNSON VISION PRODU (US) 2003-08-13 CN claimed
JP-9272829-A None JP disclosed
JP-2069501-A None JP disclosed
US-4588786-A ACID SALT AND PRIMARY AMINE NIPPON ZEON CO., LTD. (JP) 1986-05-13 US disclosed
US-4048416-A ION EXCHANGE RESINS EXPLOATERINGS AKTIEBOLAGET T.B.F. (SW) 1977-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11801211-B2 Hair treatment formulations and uses thereof FHIT, SUCLG1, TES CA1 1805/4885CA2 918/4885CA9 2073/4885
US-20230099154-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF FHIT, SUCLG1, TES CA1 1805/4885CA2 918/4885CA9 2073/4885
US-12214065-B2 Diester cosmetic formulations and uses thereof DAGLA, CYP19A1, CYP51A1 CA1 3300/4885CA2 2399/4885CA9 1391/4885
US-11491092-B2 Hair treatment formulations and uses thereof FHIT, SUCLG1, TES CA1 1805/4885CA2 918/4885CA9 2073/4885
US-12285508-B2 Hair treatment formulations and uses thereof FHIT, SUCLG1, TES CA1 1805/4885CA2 918/4885CA9 2073/4885
US-20230140697-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF FHIT, SUCLG1, TES CA1 1805/4885CA2 918/4885CA9 2073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.